Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients

BACKGROUND. Bevacizumab leads to improved survival for patients with metastatic colorectal cancer (CRC) or non-small cell lung cancer (NSCLC) when added to chemotherapy. Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mohile, Supriya G., Hardt, Molly, Tew, William, Owusu, Cynthia, Klepin, Heidi, Gross, Cary, Gajra, Ajeet, Lichtman, Stuart M., Feng, Tao, Togawa, Kayo, Ramani, Rupal, Katheria, Vani, Hansen, Kurt, Hurria, Arti
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2013
Sujets:
Geriatric Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3639527/
https://ncbi.nlm.nih.gov/pubmed/23576485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0351
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires